Key result
Type 2 diabetes and metabolic syndrome were associated with higher CAD prevalence on 64-slice CT (78% and 65%, respectively) compared to a comparison group (55%, p<0.05).
Why the study?
The study was conducted to determine the prevalence, morphology, and severity of coronary artery plaque in high-risk patients using 64-slice cardiovascular computed tomography.
Does 64-slice CVCT identify differences in coronary atherosclerosis prevalence, severity, and morphology among patients with type 2 diabetes, metabolic syndrome, and a comparison group?
Observational (n=101)
Does 64-slice CVCT identify differences in coronary atherosclerosis prevalence, severity, and morphology among patients with type 2 diabetes, metabolic syndrome, and a comparison group?
Absolute Event Rate: 78% vs 55%
p-value: p=<0.05
64-slice CVCT identifies distinct patterns of coronary atherosclerosis, showing higher CAD prevalence and severity in diabetics and more vulnerable plaques in metabolic syndrome patients.
May inform CT-based risk stratification in diabetes and metabolic syndrome; leaves open prospective outcome validation before practice change.
Background: We determined the prevalence, morphology, and severity of coronary artery plaque in high-risk patients via 64- slice cardiovascular computed tomography (CVCT). Methods: Based on chart review, 101 subjects having a 64-slice CVCT were assigned to one of three groups: type 2 diabetes, metabolic syndrome, or comparison. Disease severity was classified as: no disease, subclinical disease (lesions <70%), or clinically significant disease (lesions >70%). Plaque morphology was stratified as either vulnerable or stable plaque by Houndsfield units and established American Heart Association criteria. Results: Diabetic subjects had the highest prevalence of CAD (78%), compared to 65% in the metabolic syndrome subjects and 55% in the comparison group (p<.05). Diabetic subjects were also most likely to have both significant CAD (41%), and stable plaque (52%) followed by metabolic syndrome subjects (33% and 25%) and the comparison group (15% and 20%) (p < 0.05). The metabolic syndrome group was most likely to have vulnerable lesions (36%) potentially placing them at increased risk of acute events. 22% of subjects in the diabetes group, 35% in the metabolic syndrome group, and 45% in the comparison cohort were disease-free. Conclusions: 64-slice CVCT allows non-invasive diagnosis and stratification of subjects with diabetes and the metabolic syndrome, providing relevant information regarding coronary disease prevalence, severity, and plaque composition, that are statistically different among these high risk patient cohorts. (Int J Diabetes Metab 14: 120-125, 2006)
No takes yet. Share an insight, caveat, or question.
J.J. et al. (2019) conducted an observational in Coronary atherosclerosis (n=101). Type 2 diabetes vs. Comparison group was evaluated on Prevalence of coronary artery disease (p=<0.05). Type 2 diabetes and metabolic syndrome were associated with higher CAD prevalence on 64-slice CT (78% and 65%, respectively) compared to a comparison group (55%, p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: